[1]
|
(2014) Mosquito-Borne Diseases. American Mosquito Control Association. http://www.mosquito.org/mosquito-borne-diseases
|
[2]
|
McFee, R.B. (2013) Viral Hemorrhagic Fever Viruses. Disease-a-Month, 59, 410-425. http://dx.doi.org/10.1016/j.disamonth.2013.10.003
|
[3]
|
(2014) Sign and Symptom of Dengue Virus. http://www.denguevirusnet.com/signs-a-symptoms.html
|
[4]
|
Mangold, K. and Reynolds, S. (2013) Review of Dengue Fever. Pediatric Emergency Care, 29, 665-669. http://dx.doi.org/10.1097/PEC.0b013e31828ed30e
|
[5]
|
Wilson, M.E., Weld, L.H., Boggild, A., Keystone, J.S., Kain, K.C., Sonnenburg, F. and Schwartz, E. (2007) Fever in Return Travellers: Result from the Geosentinel Surveillance Network. Clinical Infectious Diseases, 44, 1560-1568. http://dx.doi.org/10.1086/518173
|
[6]
|
Government of Canada (2014) Dengue Fever. http://travel.gc.ca/travelling/health-safety/diseases/dengue
|
[7]
|
Sizmur, C. (2014) Malaysia Steps up Campaign against Dengue. http://www.publichealth.basf.com/agr/ms/public-health/en_GB/content/public-health/our-partners/Dengue/dengue_in_malaysia
|
[8]
|
Hu, H., Nigmatulina, K. and Eckhoff, P. (2013) The Scaling of Contact Rates with Population Density for the Infectious Disease Models. Mathematical Biosciences, 244, 125-134. http://dx.doi.org/10.1016/j.mbs.2013.04.013
|
[9]
|
Tam, J.S., Barbeschi, M., Shapovalova, N., Briand, S., Memish, Z.A. and Kieny, M.P. (2012) Research Agenda for Mass Gatherings: A Call to Action. Lancet Infection, 12, 231-239. http://dx.doi.org/10.1016/s1473-3099(11)70353-x
|
[10]
|
Miller, J.C. and Voltz, E.M. (2013) Incorporating Disease and Population Structure into Models of SIR Disease in Contact Networks. PloS One, 8, 1-14. http://dx.doi.org/10.1371/journal.pone.0069162
|
[11]
|
Wongkoon, S., Jaroensutasinee, M. and Jaroensutasinee, K. (2013) Distribution, Seasonal Variation & Dengue Transmission Prediction in Sisaket, Thailand. Indian Journal of Medical Research, 138, 347-353.
|
[12]
|
Colon-Gonzalez, F.J., Fezzi, C., Lake, I.R. and Hunter, P.R. (2013) The Effects of Weather and Climate Change on Dengue. PLoS Neglected Tropical Diseases, 7, 1-9. http://dx.doi.org/10.1371/journal.pntd.0002503
|
[13]
|
WHO (2015) Dengue Fever Fact Sheet No 117. Updated January 2015. http://www.who.int/mediacentre/factsheets/fs117/en/
|
[14]
|
Malaysia Remote Sensing Agency (2014) http://idengue.remotesensing.gov.my/.
|
[15]
|
Sue-Chern, L. (2014) As Dengue Death Rise, Will Malaysia Try Breeding Out “Bad” Aedes? The Malaysian Insider. http://www.themalaysianinsider.com/malaysia/article/asdengue-deaths-rise-will-malaysia-try-breeding-out-badaedes
|
[16]
|
Paul, B. and Tham, W.L. (2015) Interrelation between Climate and Dengue in Malaysia. Health, 7, 672-678. http://dx.doi.org/10.4236/health.2015.76080
|
[17]
|
Yacouba, S., Mongkolsapayaa, J. and Screatona, G. (2013) Pathogenesis of Dengue. Current Opinion of Infectious Disease, 26, 284-289. http://dx.doi.org/10.1097/QCO.0b013e32835fb938
|
[18]
|
Normile, D. (2014) Surprising New Dengue Virus Throws a Spanner in Disease Control Efforts. Science, 342, 415. http://dx.doi.org/10.1126/science.342.6157.415
|
[19]
|
Fu, J., Tan, B.H., Yap, E.H., Chan, Y.C. and Tan, Y.H. (1992) Full-Length cDNA Sequence of Dengue Type 1 Virus (Singapore Strain S275/90). Virology, 188, 953-958. http://dx.doi.org/10.1016/0042-6822(92)90560-C
|
[20]
|
Putnak, J.R., Charles, P.C., Padmanabhan, R., Irie, K., Hoke, C.H. and Burke, D.S. (1988) Functional and Antigenic Domains of the Dengue-2 Virus Nonstructural Glyco-protein NS-1. Virology, 163, 93-103. http://dx.doi.org/10.1016/0042-6822(88)90236-X
|
[21]
|
Lim, S.P., Ooi, E.E. and Vasudevan, S.G. (2004) Full Length Genomic Sequence of a Dengue Virus of Serotype 3 from Singapore. (Un-published)
|
[22]
|
Durbin, A.P., Karron, R.A., Sun, W., Vaughn, D.W., Reynolds, M.J., Perreault, J.R., Thumar, B., Men, R., Lai, C.J., Elkins, W.R., Chanock, R.M., Murphy, B.R. and Whitehead, S.S. (2001) Attenuation and Immunogenicity in Humans of a Live Dengue Virus Type-4 Vaccine Candidate with a 30 Nucleotide Deletion in Its 3’-Untranslated Region. Annual Journal of Tropical Medicine Hygiene, 65, 405-413.
|
[23]
|
Wallner, G., Mandl, C.W., Kunz, C. and Heinz, F.X. (1995) The Flavivirus 3’-Noncoding Region: Extensive Size Heterogeneity Independent of Evolutionary Relationships among Strains of Tick-Borne Encephalitis Virus. Virology, 213, 196-178. http://dx.doi.org/10.1006/viro.1995.1557
|
[24]
|
Shah, P.S., Tanaka, M., Khan, A.H., Mathenge, E.G., Fuke, I., Takagi, M., Igarashi, A. and Morita, K. (2006) Molecular Characterization of Attenuated Japanese Encephalitis Live Vaccine Strain ML-17. Vaccine, 24, 402-411. http://dx.doi.org/10.1016/j.vaccine.2005.10.048
|
[25]
|
Ciota, A.T., Lovelace, A.O., Ngo, K.A., Le, A.N., Maffei, J.G., Franke, M.A., Payne, A.F., Jones, S.A., Kauffman, E.B. and Kramer, L.D. (2007) Cell-Specific Adaptation of Two Flaviviruses Following Serial Passage in Mosquito Cell Culture. Virology, 357, 165-174. http://dx.doi.org/10.1016/j.virol.2006.08.005
|
[26]
|
McMullen, A.R., Albayrak, H., May, F.J., Davis, C.T., Beasley, D.W. and Barrett, A.D. (2013) Molecular Evolution of Lineage 2 West Nile Virus. Journal of General Virology, 94, 318-325. http://dx.doi.org/10.1099/vir.0.046888-0
|
[27]
|
Rice, C.M., Lenches, E.M., Eddy, S.R., Shin, S.J., Sheets, R.L. and Strauss, J.H. (1985) Nucleotide Sequence of Yellow Fever Virus: Implications for Flavivirus Gene Expression and Evolution. Science, 229, 726-733. http://dx.doi.org/10.1126/science.4023707
|
[28]
|
Khan, A.H., Morita, K., Parquet, M., Parquet, M. del C., Mathenge, E.G. and Igarashi, A. (2002) Complete Nucleotide Sequence of Chikungunya Virus and Evidence for an Internal Polyadenylation Site. Journal of General Virology, 83, 3075-3084. http://dx.doi.org/10.1099/0022-1317-83-12-3075
|
[29]
|
Rodenhuis-Zybert, I.A., Wilschut, J. and Smit, J.M. (2010) Dengue Virus Life Cycle: Viral and Host Factors Modulating Infectivity. Cellular and Molecular Life Sciences, 67, 2773-2786. http://dx.doi.org/10.1007/s00018-010-0357-z
|
[30]
|
Perera, R. and Kuhn, R.J. (2008) Structural Pro-teomics of Dengue Virus. Current Opinion in Microbiology, 11, 169-178. http://dx.doi.org/10.1016/j.mib.2008.06.004
|
[31]
|
Jain, B., Chaturvedi, U.C. and Jain, A. (2014) Role of Intracellular Events in the Pathogenesis of Dengue: An Overview. Microbial Pathogenesis, 69-70, 45-48. http://dx.doi.org/10.1016/j.micpath.2014.03.004
|
[32]
|
Belosovic, M. (2014) Plasmodium sp. Zoology 352 Lecture Series, University of Alberta, Edmonton.
|
[33]
|
Buret, A.G. (2014) Pathogenesis of Parasitic Disease. Zoology 352 Lecture Series, University of Alberta, Edmonton.
|
[34]
|
Gubler, D.J. (2010) Dengue Viruses. In: Mahy, B.W.J. and Van Regenmortel, M.H.V., Eds., Desk Encyclopedia of Human and Medical Virology, Academic Press, Boston, 372-382.
|
[35]
|
Povoa, T.F., Alves, A.M.B., Oliveira, C.A.B., Nuovo, G.J., Chagas, V.L.A. and Paes, M.V. (2014) The Pathology of Severe Dengue in Multiple Organs of Human Fatal Cases: Histopathology, Ultrastructure and Virus Replication. PloS ONE, 9, 1-16. http://dx.doi.org/10.1371/journal.pone.0083386
|
[36]
|
Ishikawaa, T., Yamanakab, A. and Konishi, E. (2014) A Review of Successful Flavivirus Vaccines and the Problems with Those Flaviviruses for Which Vaccines Are Not Yet Available. Vaccine, 32, 1326-1337. http://dx.doi.org/10.1016/j.vaccine.2014.01.040
|
[37]
|
Hoffmann, M.P. and Frodsham, A.C. (1993) Natural Enemies of Vegetable Insect Pests. Cooperative Extension, Cornell University, Ithica, 63 p.
|
[38]
|
Bellows, T.S. (2001) Restoring Population Balance through Natural Enemy Introductions. Biological Control, 21, 199-205. http://dx.doi.org/10.1006/bcon.2001.0936
|
[39]
|
Marimuthu, S., Rahuman, A.A., Kirthi, A.V., Santhoshkumar, T., Jayaseelan, C. and Rajakumar, G. (2013) Eco-Friendly Microbial Route to Synthesize Cobalt Nanoparticles Using Bacillus thuringiensis against Malaria and Dengue Vectors. Parasitology Resources, 112, 4105-4112. http://dx.doi.org/10.1007/s00436-013-3601-2
|
[40]
|
Lee, H.L., Chen, C.D., Masri, S.M., Chiang, Y.F., Chooi, K.H. and Benjamin, S. (2008) Impact of Larvaciding with a Bacillus thuringiensis isrealensis Formulation, VectoBac WG, on Dengue Mosquito Vectors in a Dengue Endemic Site in Selangor State Malaysia. Southeast Asian Journal Tropical Medicine Public Health, 39, 601-609.
|
[41]
|
Kozek, W. and Rao, R. (2007) The Discovery of Wolbachia in Arthropods and Nematodes—A Historical Perspective. Issues in Infectious Diseases, 5, 1-14. http://dx.doi.org/10.1159/000104228
|
[42]
|
Turley, A.P., Moreira, L.A., O’Neill, S.L. and McGraw, E.A. (2009) Wolbachia Infection Reduces Blood-Feeding Success in the Dengue Fever Mosquito, Aedesaegypti. PLoS Neglected Tropical Diseases, 3, 1-7. http://dx.doi.org/10.1371/journal.pntd.0000516
|
[43]
|
Hancock, P.A., Sinkins, S.P. and Godfray, H.C.J. (2011) Strategies for Introducing Wolbachia to Reduce Transmission of Mosquito-Borne Diseases. PLoS Neglected Tropical Diseases, 5, 1-10. http://dx.doi.org/10.1371/journal.pntd.0001024
|
[44]
|
Hoffmann, A.A., Iturbe-Ormaetxe, I., Callahan, A.G., Phillips, B.L., Billington, K., Axford, J.K., Montgomery, B., Turley, A.P. and O’Neill, S.L. (2014) Stability of the wMel Wolbachia Infection Following Invasion into Aedesaegypti Populations. PLoS Neglected Tropical Diseases, 8, 1-9. http://dx.doi.org/10.1371/journal.pntd.0003115
|
[45]
|
Frentiu, F.D., Zakir, T., Walker, T., Popovici, J., Pyke, A.T., Van Der Hurk, A., McGraw, A.E. and O’Neill, S.L. (2014) Limited Dengue Virus Replication in Field-Collected Aedesaegypti Mosquitoes Infected with Wolbachia. PLoS Neglected Tropical Disease, 8, e2688. http://dx.doi.org/10.1371/journal.pntd.0002688
|
[46]
|
Baron, S., Ed. (1996) Medical Microbiology. 4th Edition, The University of Texas Medical Branch at Galveston, Galveston.
|
[47]
|
Chatterjee, S., Ghosh, T.S. and Das, S. (2010) Virulence of Bacillus cereus as Natural Facultative Pathogen of Anopheles subpictus Grassi (Diptera: Culicidae) Larvae in Submerged Rice-Fields and Shallow Ponds. African Journal of Biotechnology, 9, 6983-6986.
|
[48]
|
Dayan, G.H., Thakur, M., Boaz, M. and Johnson, C. (2013) Safety and Immunogenicity of Three Tetravalent Dengue Vaccine Formulations in Healthy Adults in the USA. Vaccine, 31, 5048-5055. http://dx.doi.org/10.1016/j.vaccine.2013.08.088
|
[49]
|
McNeil, M.M., Gee, J., Weintraub, E.S., Belongia, E.A., Lee, G.M., Glanz, J.M., Nordin, J.D., Klein, N.P., Baxter, R., Naleway, A.L., Jackson, L.A., Omer, S.B., Jacobsen, S.J. and DeStefano, F. (2014) The Vaccine Safety Datalink: Successes and Challenges Monitoring Vaccine Safety. Vaccine, 32, 5390-5399. http://dx.doi.org/10.1016/j.vaccine.2014.07.073
|
[50]
|
Heinz, F.X. and Stiasny, K. (2012) Flaviviruses and Flavivirus Vaccines. Vaccine, 30, 4301-4307. http://dx.doi.org/10.1016/j.vaccine.2011.09.114
|
[51]
|
Hemming, D. (2014) Immune Regulation to Post 2014. Immunology 371 Lecture Series, University of Alberta, Edmonton.
|
[52]
|
Watanaveeradej, V., Gibbons, R.V., Simasathien, S., Nisalak, A., Jarman, R.G., Kerdpanich, A., Tournay, E., De La Barrerra, R., Dessy, F., Toussaint, J.F., Eckels, K.H., Thomas, S.J. and Innis, B.L. (2014) Safety and Immunogenicity of a Rederived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults Living in Thailand: A Randomized Trial. American Journal of Tropical Medicine and Hygiene, 91, 119-128. http://dx.doi.org/10.4269/ajtmh.13-0452
|
[53]
|
Bhamarapravati, N. and Sutee, Y. (2000) Live Attenuated Tetravalent Dengue Vaccine. Vaccine, 18, 44-47. http://dx.doi.org/10.1016/S0264-410X(00)00040-2
|
[54]
|
Guirakhoo, F., Weltzin, R., Chambers, T.J., Zhang, Z.-X., Soike, K., Ratterree, M., Arroyo, J., Georgakopoulos, K., Catalan, J. and Monath, T.P. (2000) Recombinant Chimeric Yellow Fever-Dengue Type 2 Virus Is Immunogenic and Protective in Nonhuman Primates. Journal of Virology, 74, 5477-5485. http://dx.doi.org/10.1128/JVI.74.12.5477-5485.2000
|
[55]
|
Guirakhoo, F., Kitchener, S., Morrison, D., Forrat, R., McCarthy, K., Nichols, R., Yoksan, S., Duan, X., Ermak, T.H., Kanesa-Thasan, N., Bedford, P., Lang, J., Quentin-Miller, M.J. and Monath, T.P. (2006) Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-Immunity in Induction of Cross Neutralizing Antibody Responses to All 4 Dengue Serotypes. Human Vaccine, 2, 60-67. http://dx.doi.org/10.4161/hv.2.2.2555
|
[56]
|
Hss, A.-S., Koh, A.-T., Tan, K.K., Chan, L.G., Zhou, L., Bouckenooghe, A., Crevat, D. and Hutagalung, Y. (2013) Safety and Immunogenicity of a Tetravalent Dengue Vaccine in Healthy Children Aged 2-11 Years in Malaysia: A Randomized, Placebo-Controlled, Phase III Study. Vaccine, 31, 5814-5822. http://dx.doi.org/10.1016/j.vaccine.2013.10.013
|
[57]
|
Huet, N. (2014) Final Trial Confirms Efficacy of Sanofi’s Dengue Vaccine. Reu-ters. http://www.reuters.com/article/2014/09/03/ussanofi-dengue-idUSKBN0GY0C520140903
|
[58]
|
Villar, L., Dayan, G.H., Arredondo-García, J.L., Rivera, D.M., Cunha, R., Deseda, C., Reynales, H., Costa, M.S., Mo-rales-Ramírez, J.O., Carrasquilla, G., Rey, L.C., Dietze, R., Luz, K., Rivas, E., Montoya, M.C.M., Supelano, M.C., Zambrano, B., Langevin, E., Boaz, M., Tornieporth, N., Saville, M. and Noriega, F. (2015) Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America. The New England Journal of Medicine, 372, 113-123. http://dx.doi.org/10.1056/NEJMoa1411037
|
[59]
|
Bernal, A. (2014) The World’s First, Large-Scale Dengue Vaccine Efficacy Study Successfully Achieved Its Primary Endpoint. Sanofi Pasteur Me-dia. http://www.sanofipasteur.com/en/articles/theworld-s-first-large-scale-dengue-vaccine-efficacy-study-successfully-achieved-its-primary-clinical-endpoint.aspx
|
[60]
|
Belosevic, M. (2014) Concept of Integrated Control against Parasites. Zoology 352 Lecture Series, University of Alberta, Edmonton.
|
[61]
|
Buret, A. (2014) Drugs and Parasites. Zoology 352 Lecture Series, University of Alberta, Edmonton.
|